PALONOSETRON RZ palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

palonosetron hydrochloride, Quantity: 280 microgram (Equivalent: palonosetron, Qty 250 microgram)

Available from:

Dr Reddys Laboratories Australia Pty Ltd

INN (International Name):

Palonosetron hydrochloride

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: sodium acetate trihydrate; water for injections; mannitol; hydrochloric acid; sodium hydroxide

Administration route:

Intravenous Infusion

Units in package:

1 x 5 mL vial

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Product summary:

Visual Identification: A clear colourless solution free from visible extraneous matters.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2016-07-13